V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190005657 | 190003970 | 0 | 45.9 | null | 2016-03-13 | 2016-04-23 | null | null | null | MIFAMURTIDE | 100411606 |
| 190005698 | 190003986 | null | null | null | null | 2018-03-09 | null | null | null | MIFAMURTIDE | 100769746 |
| 190005761 | 190004004 | null | null | null | null | 2022-03-16 | null | null | null | MIFAMURTIDE | 100805211 |
| 190005786 | 190004013 | null | null | null | null | 2021-05-08 | null | null | null | MIFAMURTIDE | 101636347 |
| 190005806 | 190004020 | null | 78.1 | null | null | 2016-05-22 | null | N | null | MIFAMURTIDE | 101213818 |
| 190005854 | 190004030 | null | null | null | null | 2016-09-03 | null | null | null | MIFAMURTIDE | 101305200 |
| 190005885 | 190004040 | null | null | null | null | 2016-06-11 | null | null | null | MIFAMURTIDE | 101822890 |
| 190005911 | 190004045 | null | null | null | null | 2017-12-11 | null | null | null | MIFAMURTIDE | 100991711 |
| 190005928 | 190004050 | null | null | null | null | 2017-08-30 | null | null | null | MIFAMURTIDE | 100283858 |
| 190006033 | 190004069 | null | null | null | null | 2018-11-01 | null | null | null | MIFAMURTIDE | 100971404 |
| 190006058 | 190004079 | null | null | null | null | 2017-06-29 | null | null | null | MIFAMURTIDE | 100800819 |
| 190006104 | 190004087 | 0 | 99.8 | null | 2018-10-23 | 2018-12-08 | null | null | null | MIFAMURTIDE | 100541214 |
| 190006164 | 190004104 | null | null | null | null | 2020-01-21 | null | null | null | MIFAMURTIDE | 101150050 |
| 190006183 | 190004109 | null | null | null | null | 2016-08-02 | null | null | null | MIFAMURTIDE | 100092411 |
| 190006322 | 190004145 | null | null | Neo-adjuvant (N) | null | 2016-05-01 | null | null | null | MIFAMURTIDE | 100325955 |
| 190006415 | 190004172 | 0 | 64 | null | 2019-03-22 | 2019-03-29 | null | null | null | MIFAMURTIDE | 100701975 |
| 190006440 | 190004174 | null | null | null | null | 2017-06-04 | null | null | null | MIFAMURTIDE | 100213886 |
| 190006565 | 190004217 | 1.61 | 37.1 | Curative (C) | 2017-06-14 | 2017-06-15 | Docetaxel | 02 | N | AVELUMAB | 101034753 |
| 190006568 | 190004218 | 1.64 | 53.1 | null | 2016-12-18 | 2016-12-21 | Cisplatin 7 day | 02 | N | CISPLATIN | 100829591 |
| 190006572 | 190004219 | 1.6 | 88 | null | 2018-06-01 | 2018-08-02 | VAC | 02 | N | EURO-EWING | 101599011 |
| 190006573 | 190004220 | 1.6 | 50.7 | Neo-adjuvant (N) | 2019-05-05 | 2019-05-19 | DHAP | 02 | null | CISPLATIN + GEMCITABINE | 101769358 |
| 190006574 | 190004221 | 1.71 | 95.4 | Palliative (P) | 2015-05-21 | 2016-04-12 | OST Euramos 1 Closed Trial - M | null | null | CEMIPLIMAB | 100422079 |
| 190006578 | 190004222 | 1.77 | 84.1 | Palliative (P) | 2016-12-24 | 2017-11-11 | EW EuroEwing 2012 Arm A VIDE | 02 | N | FLUOROURACIL + IRINOTECAN | 101314555 |
| 190006579 | 190004223 | 1.85 | 94 | Palliative (P) | 2018-10-15 | 2018-11-06 | CISPLATIN + GEMCITABINE | 02 | Y | TOPOTECAN | 100735742 |
| 190006582 | 190004224 | 1.67 | 52 | 03 | 2020-06-06 | 2020-07-19 | Carboplatin AUC 2 - 5 | Y | N | CARBOPLATIN | 101629290 |
| 190006583 | 190004225 | 1.74 | 56 | Curative (C) | 2018-01-23 | 2018-07-28 | EW Rel rEECur Ifosfamide | 02 | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100527781 |
| 190006584 | 190004226 | 1.73 | 59.7 | Curative (C) | null | 2018-11-22 | Ixazomib + Lenalidomide | 2 | N | CISPLATIN + GEMCITABINE | 100741993 |
| 190006589 | 190004227 | 1.79 | 52 | Palliative (P) | 2019-04-02 | 2019-04-16 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101463706 |
| 190006593 | 190004228 | 1.77 | 67.6 | Palliative (P) | 2019-12-28 | 2019-12-31 | GEMCITABINE + TREOSULPHAN | 02 | N | GEMCITABINE | 101561777 |
| 190006594 | 190004229 | 1.72 | 59.7 | null | 2021-04-17 | 2021-04-17 | OST Euramos 1 Closed Trial - AP | 02 | N | FLUOROURACIL + IRINOTECAN | 101130836 |
| 190006595 | 190004230 | 1.6 | 61.2 | Curative (C) | null | 2019-03-28 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | null | null | PEMBROLIZUMAB | 101300360 |
| 190006600 | 190004231 | 1.78 | 74 | null | 2017-03-13 | 2017-03-13 | EURAMOS TRIAL | 02 | N | CAPECITABINE + CARBOPLATIN | 101507178 |
| 190006606 | 190004232 | 1.6 | 54.5 | Curative (C) | 2017-08-02 | 2017-08-05 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101838365 |
| 190006609 | 190004233 | 1.57 | 61.5 | Neo-adjuvant (N) | 2017-01-07 | 2017-01-22 | LIPOSOMAL DOXORUBICIN | 01 | N | DOCETAXEL | 101341901 |
| 190006617 | 190004234 | 0 | 25.3 | null | 2018-12-27 | 2018-12-31 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100764044 |
| 190006620 | 190004235 | null | 53.2 | null | 2018-03-16 | 2018-03-26 | EURO-EWING | 01 | null | FLUOROURACIL + IRINOTECAN | 100026419 |
| 190006625 | 190004236 | 1.58 | null | Curative (C) | 2017-01-26 | 2017-02-01 | Cisplatin | 02 | null | CISPLATIN | 100637132 |
| 190006627 | 190004237 | 1.51 | 38.25 | Curative (C) | 2018-06-28 | 2018-07-12 | Cisplatin + Docetaxel | 02 | N | CAPECITABINE | 101473705 |
| 190006630 | 190004238 | null | 93.8 | Curative (C) | 2016-08-01 | 2016-09-05 | Capecitabine + Oxaliplatin 21day | 02 | N | ETOPOSIDE | 101493865 |
| 190006635 | 190004239 | 1.57 | 68.7 | Palliative (P) | 2012-06-28 | 2012-11-29 | OST Mifamurtide | 01 | N | LANREOTIDE | 100962844 |
| 190006648 | 190004240 | 1.61 | 76 | null | 2018-09-09 | 2018-10-21 | DHAP | 02 | Y | EW REL REECUR GEMCITABINE/DOCETAXEL | 101620910 |
| 190006655 | 190004241 | null | 55.3 | Neo-adjuvant (N) | 2018-10-26 | 2018-10-26 | Cyclophosphamide + Topotecan | 02 | N | CARBOPLATIN + FLUOROURACIL | 101109001 |
| 190006656 | 190004242 | 1.62 | 49.7 | null | 2017-08-12 | 2017-08-12 | Docetaxel 100mg/m2 (21 day) | 01 | N | OXALIPLATIN + MDG | 101323844 |
| 190006657 | 190004243 | 1.8 | 43 | Adjuvant (A) | 2017-11-25 | 2017-12-08 | STS Rhabdo RMS 2005 2nd Topo Cyclo | 02 | N | PACLITAXEL | 100826630 |
| 190006661 | 190004244 | 1.88 | 79 | null | 2018-10-17 | 2018-12-31 | Irinotecan + Modified De Gramont | 02 | Y | LANREOTIDE | 100283519 |
| 190006662 | 190004245 | 0 | 0 | Adjuvant (A) | 2019-10-25 | 2019-10-25 | OST Rel Ifosfamide Etoposide Mtx | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100617822 |
| 190006671 | 190004246 | 1.61 | 65 | Curative (C) | 2020-02-12 | 2020-02-15 | GEMCITABINE | 02 | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100310530 |
| 190006672 | 190004247 | 1.69 | 63.4 | Adjuvant (A) | 2019-05-30 | 2019-06-02 | Cyclophosphamide + Vincristine | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 101330047 |
| 190006680 | 190004248 | 1.8 | 49.6 | null | 2017-11-18 | 2017-11-19 | PAM x 2 post-surgery (cycles 3&4) | N | N | CARBOPLATIN + ETOPOSIDE | 100071578 |
| 190006691 | 190004249 | 1.79 | 53.35 | Adjuvant (A) | null | 2017-03-06 | Cisplatin + Radiotherapy | null | null | ENZALUTAMIDE | 100660804 |